pfizer lot number lookup covid vaccine
For example, if the manufacture date is August 2021 (8/21), include August as one of the 12 months; the expiration date will be January 2023 (1/31/23). . Learn how your gifts makes that possible. Pfizer Covid Vaccine Lot Number Lookup Expiration Date Covid 2022. Based on the shelf life currently approved in United States of America (USA), the Expiry Date for Lot # (AB0000) is: September 27, 2022. Additional code details and fields values are included in the vaccine code sets. Expires 18 months after manufacture, if held at Ultra Cold temperatures. There are multiple COVID-19 vaccines authorized for use across several brands (Moderna, Pfizer-BioNTech, Janssen, Novavax) . Share price feed News Releases 09.12.22. FDA Fact Sheet for Health Care Providers Administering Vaccine (5 through 11 years), BIVALENT (Original and Omicron) CDC US COVID-19 Vaccine Product InformationCDC Storage and Handling of Pfizer-BioNTech COVID-19 Vaccines. The FDA issued its initial Emergency Use Authorization for the Janssen (Johnson & Johnson) COVID-19 vaccine on Saturday February 27, 2021. B~o[_o$Pz{%y .=8X Selection required to narrow down to correct Administrative Code. So a lot of healthcare stocks, I like all the healthcare stocks. Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) Formulation does NOT have expiration printed on vial Instead, each vial has the lot number and date of manufacture printed on the label The lot number is a string of numbers and letters that tracks this specific batch of vaccine . The CPT vaccine product codes are included in the Preview COVID-19 table and the CDC vaccine code sets. Note: Highlighted cells indicate recently changed or new data since the last version. When you are uploading your vaccine information (primary vaccine or booster), you will . By Emma Cott , Elliot deBruyn and Jonathan Corum April 28, 2021. Copyright 1995 - 2023 American Medical Association. 0310-1222-10 00310-1222-10. . Pfizer vaccine has the expiration date on the vial; for Moderna and Janssen, scan QR codes. The vaccine expires 18 months after manufacture date if stored frozen at ultra-cold temperatures (-90C to -60C [-130F to -76F]). 5 through 11 years formulation (orange cap) o formulation does not have expiration printed on vial o instead, each vial has the lot number and date of manufacture printed on the label o. New concentration, 50 mcg/0.50 mL for booster dose adults 18+ yrs, also authorized for primary series and IC doses for ages 6 years to <12 years. All information these cookies collect is aggregated and therefore anonymous. To receive email updates about this page, enter your email address: We take your privacy seriously. The vaccine expires on the last day of the 18th month. 1805025 5/25/2021 029A21A 5/22/2021 EL8982 5/31/2021 To support this effort, the CDC is working closely with data partners responsible for the creation and distribution of vaccine codes and drug compendia publishers to coordinate the release of codes in advance of potential EUAs to enable systems and users that require these codes to prepare in advance. The vaccine expires on the last day of the 18th month. The Pfizer-BioNTech COVID-19 Vaccine, the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, or COMIRNATY (COVID-19 Vaccine, mRNA) will be given to you as an injection into the . Get the latest news from the AAP including press statements, the AAP Voices Blog, the Pediatrics OnCall Podcast and more! These cookies may also be used for advertising purposes by these third parties. Count out 18 months, using the month printed on the vial as month 1. Data.CDC.gov. Authorized by WHO 10/19/2022 Counted toward immunity in US, Pfizer COVID-19 Bivalent, Original + BA.1 (Non-US Tradename COMIRNATY Bivalent), COVID-19 Moderna Vaccine EUA Recipient-Caregiver Fact Sheet 6 yrs and older, COVID-19 Moderna EUA Recipient-Caregiver Fact Sheet Pediatric 6mo to <6yrs, COVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet 12 years and older, COVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet- Pediatric 5yrs to <12 yrs, COVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet- Pediatric <5 yrs, COVID-19 Janssen Vaccine EUA Recipient-Caregiver Fact Sheet, COVID-19 Novavax EUA Recipient-Caregiver Fact Sheet, Centers for Disease Control and Prevention. The lot number you entered (AB0000) does not exist. Storage for longer than 10 weeks requires an Ultra Cold freezer. (lymphocyte immune globulin, anti-thymocyte globulin [equine] sterile solution), (penicillin G benzathine and penicillin G procaine injectable suspension), (amlodipine besylate/atorvastatin calcium), (alprostadil injection, powder, lyophilized, for solution), (neomycin and polymyxin B sulfates, and hydrocortisone acetate), (verapamil hydrochloride extended-release), (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution, (methylprednisolone acetate injectable suspension), (medroxyprogesterone acetate injectable suspension), (phenytoin oral suspension, phenytoin, and extended phenytoin sodium), (diphenoxylate hydrochloride with atropine sulfate), (pregabalin) and (pregabalin extended release tablets), (relugolix, estradiol, and norethindrone acetate), (neomycin and polymyxin B sulfates, and gramicidin), (immune globulin intravenous, human - ifas), (potassium chloride, sodium chloride, calcium chloride, and magnesium chloride), (conjugated estrogens/medroxyprogesterone acetate), (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 Protein]), (Pneumococcal 20-valent Conjugate Vaccine), (monobasic sodium phosphate and dibasic sodium phosphate), (sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous), levonorgestrel and ethinyl estradiol - triphasic regimen, (doxycycline calcium, doxycycline hyclate, doxycycline monohydrate), Unleashing the next wave of scientific innovations, Research and Business Development Partnerships, IXIFI for injection, for Intravenous Use, NORMINEST FE Tablets and NORQUEST FE Tablets, VYNDAQEL (tafamidis meglumine) Capsules and VYNDAMAX (tafamidis) Capsules, XTANDI (enzalutamide) capsules, for oral use. Vaccine is . The above NDCs should be retired in systems effective 08/01/2022. A carton 0f 10 multiple-dose vials may take up to 6hours to thaw at this temperature. AAP original research, including a robust practice-based research network, addresses important questions regarding pediatric practice and the health and well being of children. Copyright 2022 American Medical Association (AMA). Android, The best in medicine, delivered to your mailbox. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. The following downloadable table provides a summary of the currently authorized vaccine codes and a preview of the vaccine codes that will be activated if the FDA authorizes use and ACIP votes to recommend the candidate vaccines. The dashboard can be found on the DPH website at https://dph.georgia.gov. Record the date and time of first use on the Moderna COVID-19 Vaccine label. CDC twenty four seven. Ultra Cold -90C to -60C (-130F to -76F)*. 2nd Dose to 3rd Dose (CDC recommended population[s] [eg, immunocomprom ised]) 28 or More Days ; Booster: Refer to FDA/CDC Guidance 91315 . Updates Children 6 months through 5 years of age are eligible to receive the bivalent Moderna COVID-19 vaccine as a booster dose at least two months after completing their two-dose monovalent Moderna primary series. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for use as a single booster dose in individuals 5 years of age and older at least two months after completion of either primary . Pfizer and Moderna are two-dose vaccines, while J&J is one dose. Sorry! EUA continues for 6 years to <12 year primary and IC doses. Thank you for taking the time to confirm your preferences. 432-US-2200431 09/22 PP-ELI-USA-0686 They help us to know which pages are the most and least popular and see how visitors move around the site. At that time, the FDA published a BLA package insert that included the new approved trade name SPIKEVAX and listed 2 new NDCs for Unit of Sale cartons (80777-100-99 and 80777-100-98). Pfizer Vials and Expiration Dates: Label Information Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) o Formulation does NOT have expiration printed on vial o Instead, each vial has the lot number and date of manufacture printed on the label o. SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, 30 mcg/0.3 mL for adult 12+ (Same as EUA tris sucrose formula), EUA-authorized for ages 5 yrs to < 12 yrs, 10 mcg/0.2 mL for primary series, IC 3rd dose, booster, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Pfizer-BioNTech COVID-19 Vaccine Bivalent Booster, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Pfizer-BioNTech COVID-19 Vaccine Bivalent 6 months through 4 years (Tris-sucrose formulation), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, 5 mcg/0.5 mL, primary series ages 12 years and older, booster ages 18 years and older, SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose, COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage, for intramuscular use, EUA Submission withdrawn. At this time, there are no plans to distribute product with these NDCs., SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg or 50 mcg dose, COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose, EUA 12/18/2020, 2-dose vaccine. Note: Codes will become effective only upon EUA issuance or BLA licensure of COVID-19 vaccine(s) by the Food and Drug Administration (FDA). Date on the label is NOT the expiration date. How Pfizer Makes Its Covid-19 Vaccine. endstream endobj 159 0 obj <>stream Skip directly to site content Skip directly to search. On 8/31/2022, EUA rescinded for adult monovalent booster. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. If the mRNA vaccine product given for the first two doses is not Vials of the vaccine were . Primary Series (Monovalent)6 months 5 years: Dark Blue Cap / Magenta Label6-11 years primary series: Dark Blue Cap / Purple Label 12 years and up: Red Cap / Light Blue Label, Updated (Bivalent) Booster 6 months 5 years: Dark Pink Cap/Label with Yellow Box6 years and up: Dark Blue Cap / Gray Border LabelNote: Both 0.25mL (6 11 years) and 0.5mL (12+ years older) doses may be withdrawn from the same multiple-dose vial. Subsequent BLA license and EUA amendments and authorizations have followed. o Request access to a new COVID-19 Vaccine Lot Number report via CDC's Vaccine Code Set Management Service (VCSMS). Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Pfizer-BioNTech COVID-19 Vaccine is supplied in a multiple-dose vial with a maroon cap and a label with a maroon border. . Please enter another Lot # or contact Pfizer Customer Service at 8006667248, option 8 OR [email protected] Vaccine has not expired. Pfizer Covid Vaccine Lot Number Lookup Expiration Date Covid 2022. These codes incorporate the specialized tracking needs of the Centers for Disease Control and Prevention (CDC) and Centers for Medicare & Medicaid Services (CMS) by identifying two code groups. Subsequent BLA license and EUA amendments and authorizations have followed. You can find the latest versions of these browsers at https://browsehappy.com. The Pfizer-BioNTech coronavirus vaccine became a target of conspiracy theories and disinformation campaigns as soon as it was announced, reaching millions of people on sites like Twitter, Reddit . Clinical trials showed that beginning 1 week after the second dose, the Pfizer-BioNTech Comirnaty COVID vaccine was about: 95% effective in protecting trial participants from COVID-19 for those 16 years and older. NOTE: Documentation of VIS information does not constitute documentation of vaccination consent. The COVID-19 Vaccine Lot Number and Expiration Date Report is available via registration only. ,W7@M"NV?lG=nVk`SJt*"75Nry"E"nP8%T&v:$'4B5 "WY2Vvf5,psc=l(Zb0|4;"on#t|uL;5p~hn;ZVAJ0yTL)L/d)K.>gb[>FpZ[LRJaRjm7v(HU{K\:{g_%N;plI|~j-;||O-RqISR0jJc[:E*\CB8 As additional stability data become available, the expiration dates for some products [] It is especially important for vaccines that are provisionally approved, such as COVID-19 vaccines. Each vial must be thawed before dilution. If received at 2C to 8C, they should be stored at 2C to 8C. EUA for Booster dose of this formulation has ended. Count out 18 months, using the month printed on the vial as month 1. 7`xk j "d%%%%`2sA09!--psT(r9e"GQ(r9:_E9+]P+{W]wE = FOi4x= FOi4xX,2H}6i[}oim ~pi>_ ?# Remember: You dont need ultra-cold storage to carry Pfizer-BioNTech COVID-19 vaccine. ( -90C to -60C ( -130F to -76F ) * Saturday February 27 2021... To -60C [ -130F to -76F ) * at 8006667248, option 8 or [ email protected ] vaccine not... Can be found on the last day of the 18th month Highlighted cells indicate recently changed or data... This page, enter your email address: We take your privacy seriously primary IC. In the vaccine were They help us to count visits and traffic so. Our site these browsers at https: //browsehappy.com and a label with maroon... Or booster ), you can always do so by going to our Policy... Manufacture, if held at Ultra Cold temperatures has the Expiration date Covid 2022 0f 10 vials. They should be retired in systems effective 08/01/2022: We take your privacy seriously 09/22 PP-ELI-USA-0686 They help to. Aggregated and therefore anonymous of VIS information does not exist ; J is dose... To enable you to share pages and content that you find interesting on CDC.gov third... Held at Ultra Cold -90C to -60C [ -130F to -76F ] ) share pages and content that find. Https: //dph.georgia.gov % y.=8X Selection required to narrow down to correct Administrative code *. Like all the healthcare stocks, I like all the healthcare stocks Covid 2022, can... Used for advertising purposes by these third parties several brands ( Moderna, Pfizer-BioNTech, Janssen, QR. Count visits and traffic sources so We can measure and improve the performance of our site a carton 0f multiple-dose... Down to correct Administrative code the latest versions of these browsers at https: //browsehappy.com this page enter... Of the vaccine expires on the vial as month 1 432-us-2200431 09/22 They! Eua amendments and authorizations have followed Saturday February 27, 2021 you find interesting on CDC.gov third! Your privacy seriously to search advertising purposes by these third parties vial with maroon. Best in medicine, delivered to your mailbox deBruyn and Jonathan Corum April 28, 2021 are uploading vaccine! For Moderna and Janssen, scan QR codes make any changes, you can always do so by to. Frozen at ultra-cold temperatures ( -90C to -60C [ -130F to -76F ] ) ) * are included the! Jonathan Corum April 28, 2021 and traffic sources so We can measure and improve the performance our. Months after manufacture date if stored frozen at ultra-cold temperatures ( -90C to -60C -130F... Does not exist using the month printed on the Moderna COVID-19 vaccine on Saturday February 27,.... Your email address: We take your privacy seriously AAP including press,!, Elliot deBruyn and Jonathan Corum April 28, 2021 address: We take your privacy seriously narrow! Y.=8X Selection required to narrow down to correct pfizer lot number lookup covid vaccine code vaccine is supplied in a multiple-dose vial a... 6 years to < 12 year primary and IC doses move around the site latest news from the AAP press. Can be found on the last version on Saturday February 27, 2021 these collect. Constitute Documentation of VIS information does not exist date and time of first use on the last day of 18th... Aap Voices Blog, the AAP Voices Blog, the Pediatrics OnCall Podcast and!. At 8006667248, option 8 or [ email protected ] vaccine has Expiration! Enter another Lot # or contact pfizer Customer Service at 8006667248, option 8 or [ email protected vaccine! Not the Expiration date CPT vaccine product given for the Janssen ( Johnson & Johnson COVID-19! Healthcare stocks, I like all the healthcare stocks, I like all the stocks! And therefore anonymous to -60C ( -130F to -76F ) * Lookup Expiration.... See how visitors move around the site -60C ( -130F to -76F ) * the as! Doses is not the Expiration date Covid 2022 dashboard can be found on the vial as 1! Months after manufacture, if held at Ultra Cold freezer this page, enter your email address: We your... A multiple-dose vial with a maroon border Emergency use Authorization for the Janssen ( Johnson Johnson! To site content Skip directly to search a Lot of healthcare stocks, I all! Johnson & Johnson ) COVID-19 vaccine is supplied in a multiple-dose vial with a maroon cap and label... Vials of the vaccine were and EUA amendments and authorizations have followed via registration only month on. Constitute Documentation of VIS information does not exist sources so We can measure and improve the of... The Moderna COVID-19 vaccine Lot Number Lookup Expiration date Report is available via registration.. 27, 2021 of first use on the vial as month 1 uploading vaccine... Monovalent booster Cold freezer ) * should be stored at 2C to,. Given for the first two doses is not vials of the 18th month address: We take your seriously., EUA rescinded for adult monovalent booster day of the 18th month EUA continues for 6 years to 12! Has the Expiration date count visits and traffic sources so We can and. Should be stored at 2C to 8C booster dose of this formulation has ended {. For use across several brands ( Moderna, Pfizer-BioNTech, Janssen, Novavax ) to correct Administrative code temperatures... % y.=8X Selection required to narrow down to correct Administrative code you entered AB0000. Your email address: We take your privacy seriously using the month printed on the DPH website at https //browsehappy.com! Lookup Expiration date Covid 2022 take up to 6hours to thaw at this temperature several brands ( Moderna,,! Email updates about this page, enter your email address: We take your privacy seriously:.. Number you entered ( AB0000 ) does not constitute Documentation of VIS information not... All information these cookies collect is aggregated and therefore anonymous enter your email address: We take your privacy.... First use on the last day of the vaccine expires 18 months after manufacture, if held at Cold. 8006667248, option 8 or [ email protected ] vaccine has the Expiration date Report is available via registration.. Always do so by going to our privacy Policy page the Preview COVID-19 and... An Ultra Cold temperatures Johnson ) COVID-19 vaccine is supplied in a multiple-dose vial with a maroon cap a. Please enter another Lot # or contact pfizer Customer Service at 8006667248 option! Cdc vaccine code sets Novavax ) to search and Moderna are two-dose,. Advertising purposes by these third parties 0 obj < > stream Skip directly to search and. Get the latest news from the AAP including press statements, the AAP Voices Blog the! And content that you find interesting on CDC.gov through third party social networking and other websites month 1 and... This temperature, delivered to your mailbox by Emma Cott, Elliot deBruyn and Jonathan April! Help us to count visits and traffic sources so We can measure and improve the performance of our site take! Stored at 2C to 8C for longer than 10 weeks requires an Ultra Cold -90C -60C! Purposes by these third parties android, the AAP Voices Blog, the Pediatrics OnCall Podcast more... Pfizer-Biontech, Janssen, Novavax ) day of the 18th month not vials the! Cookies used to enable you to share pages and content that you find on. And authorizations have followed 09/22 PP-ELI-USA-0686 They help us to know which pages are the most and popular... Be used for advertising purposes by these third parties fields values are included in the vaccine 18. Of healthcare stocks, I like all the healthcare stocks, I like all the stocks! And pfizer lot number lookup covid vaccine popular and see how visitors move around the site Expiration date Covid 2022 Johnson ) COVID-19 on... Networking and other websites how visitors move around the site with a maroon cap and a label with maroon! The 18th month can measure and improve the performance of our site vaccines. ] ) 18 months after manufacture, if held at Ultra Cold freezer authorized for use several... And more and IC doses & Johnson ) COVID-19 vaccine Lot Number you entered ( AB0000 ) does not.. Cott, Elliot deBruyn and Jonathan Corum April 28, 2021 _o $ Pz { % y.=8X Selection to. For longer than 10 weeks requires an Ultra Cold temperatures the mRNA product... Date on the vial ; for Moderna and Janssen, Novavax ) and other websites requires an Ultra -90C... Not exist if held at Ultra Cold -90C to -60C [ -130F to -76F *... Novavax ) the Preview COVID-19 table and the CDC vaccine code sets to! The DPH website at https: //browsehappy.com thank you for taking the time to confirm your preferences date stored! Cookies collect is aggregated and therefore anonymous vaccine Lot Number Lookup Expiration date Covid 2022 parties. Address: We take your privacy seriously additional code details and fields values are included in the vaccine code.. Emergency use Authorization for the Janssen ( Johnson & Johnson ) COVID-19 vaccine is supplied in a multiple-dose with! At Ultra Cold freezer $ Pz { % y.=8X Selection required to narrow down to correct Administrative.... ) COVID-19 vaccine Lot Number and pfizer lot number lookup covid vaccine date ( Johnson & Johnson ) COVID-19 label... Your email address: We take your privacy seriously the healthcare stocks to go back make... While J & amp ; J is one dose vaccine code sets option 8 or email! Booster ), you will Cold -90C to -60C ( -130F to -76F ) * across brands. Page, enter your email address: We take your privacy seriously content Skip directly site! & amp ; J is one dose ( Johnson & Johnson ) COVID-19 vaccine label enable you share. We take your privacy seriously details and fields values are included in the Preview COVID-19 table and the CDC code.
